Author:
Koshimichi Hiroki,Tsuda Yoshiyuki,Ishibashi Toru,Wajima Toshihiro
Reference14 articles.
1. Safety, tolerability, and pharmacokinetics of the novel anti-influenza agent baloxavir marboxil in healthy adults: phase I study findings;Koshimichi;Clin Drug Investig,2018
2. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection;Fukao;J Antimicrob Chemother,2018
3. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models;Bergstrand;AAPS J,2011
4. Stability and performance of a population pharmacokinetic model;Ette;J Clin Pharmacol,1997
5. A size standard for pharmacokinetics;Holford;Clin Pharmacokinet,1996
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献